| Identification | |
| Name: | Docosanamide, N-(1-b-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- |
| Synonyms: | BH-AC;Behenoylcytosine arabinoside;Enocitabine;N4-Behenoyl-1-b-D-arabinofuranosylcytosine;N4-Behenoylcytosine arabinoside;NSC 239336;Sunrabin; |
| CAS: | 55726-47-1 |
| Molecular Formula: | C31H55 N3 O6 |
| Molecular Weight: | 565.89 |
| InChI: | InChI=1/C31H55N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(36)32-26-22-23-34(31(39)33-26)30-29(38)28(37)25(24-35)40-30/h22-23,25,28-30,35,37-38H,2-21,24H2,1H3,(H,32,33,36,39)/t25-,28-,29+,30-/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | °C |
| Boiling Point: | °Cat760mmHg |
| Density: | 1.16g/cm3 |
| Refractive index: | 1.554 |
| Solubility: | Insoluble |
| Specification: |
Enocitabine (55726-47-1) is a nucleoside analog which can be used as chemotherapy under the brand name Sunrabin. Sunrabin can cause allergic reactions because it contains the emulsifier HCO-60 . Enocitabine (55726-47-1) is also known as Enocitabine [INN:JAN] ; Behenoylcytosine arabinoside ; Enocitabina ; Enocitabina [INN-Spanish] ; Enocitabinum ; Enocitabinum [INN-Latin] ; N(sup 4)-Behenoyl-1-beta-D-arabinofuranosylcytosine ; N(sup 4)-Behenoylcytosine arabinoside ; N-(1-beta-D-Arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)docosanamide ; Sunrabin ; Docosanamide, N-(1-beta-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- . |
| Flash Point: | °C |
| Storage Temperature: | Store in original container in a cool dark place. |
| Usage: | An antineoplastic. A derivative of Cytarabine |
| Safety Data | |
 |
|
